Cellares CEO on $380M collaboration with Bristol Myers Squibb and its impact
CEO & Founder Conversations
•
6m 18s
Cellares and Bristol Myers Squibb have entered a $380M collaboration to enhance the manufacturing of CAR T cell therapies.
Cellares Co-Founder & CEO Fabian Gerlinghaus talks about the terms of the agreement, its impact and future partnership plans on #NYSEFloorTalk with Judy Khan Shaw.
Up Next in CEO & Founder Conversations
-
Clip Founder + CEO Adolfo Babatz join...
About Clip:
The story of Clip: La Fintech #1 in Mexico
Founded in 2012 by Adolfo Babatz, Clip was born with the mission of helping businesses obtain Digital Payment solutions. The company made its first transaction in 2013 and has since led the fintech sector in Mexico as a supplier of payment ...
-
Viking CEO on what sets it apart from...
Tor Hagen, Chairman + CEO of Viking, sat down with Judy Shaw after Viking’s IPO to talk about what sets it apart from other cruise companies and why now was the right time to go public. #NYSEFloorTalk
-
Open English Founder + CEO Andres Mor...
About Open English:
Open English is the #1 online English learning method in Latin America and the US Hispanic market
Our interactive technology delivers live online classes for adults, children and businesses taught by native-English speakers 24 hours a day, 7 days a week.
Product Offering
A ...
